Post-earnings recap
Reported
Thu, Oct 28, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AstraZeneca reported an EPS of $1.50, slightly missing expectations. The stock reacted negatively, declining by 0.98%. The lack of revenue figures and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.50 | N/A | -0.53% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.